• Gamithromycin PK/PD in Cattle: Tissue-Cage Evidence

  2026-09-28

  A 2025 cattle tissue-cage study linked gamithromycin exposure to antibacterial effects against Pasteurella multocida and identified AUC0–24h/MIC as the most informative PK/PD index among those assessed. Its compartment-specific target estimates offer a framework for interpreting exposure in serum and inflammatory fluids, while the model’s limits caution against treating them as direct lung or clinical dosing targets.

• O6-Benzylguanine: MGMT Inhibition Workflows

  2026-09-27

  Use O6-Benzylguanine to distinguish direct MGMT enzyme inhibition from gene-expression changes when testing alkylator response. This practical workflow pairs activity measurements with DNA-damage and viability readouts, with controls to help separate sensitization from compound or vehicle effects.

• Tin Mesoporphyrin IX: HO Inhibition Research Guide

  2026-09-26

  Tin Mesoporphyrin IX (chloride) is a competitive inhibitor of heme oxygenase activity with a reported in vitro Ki of 14 nM against rat splenic microsomal heme oxygenase. It is a tool for studying heme catabolism, but the cited hepatitis B study examined HO-1 induction by isochlorogenic acid A and did not test Tin Mesoporphyrin IX.

• AP-2α Suppresses MGMT in Recurrent GBM

  2026-09-25

  The study links AP-2α directly to repression of MGMT, a DNA-repair enzyme associated with temozolomide resistance in recurrent glioblastoma. Cell and mouse experiments suggest that restoring AP-2α, including through retinoic acid signaling, can increase DNA-damage readouts and improve responses to temozolomide, although further work is needed to establish clinical relevance.

• CD40–STING–TRAF2 Signaling in ESCC TLS

  2026-09-25

  A study of treatment-naïve esophageal squamous cell carcinoma links tertiary lymphoid structures with favorable survival and identifies IRF4-high B cells as a prominent immune feature. Its mechanistic experiments suggest that CD40 and STING compete for TRAF2, influencing STING modification and non-canonical NF-κB signaling during B-cell activation.

• From Cilia Biology to Selective HDAC6 Research

  2026-09-24

  SMPD4 research reveals how lipid metabolism supports neural progenitor survival and primary cilia development. Here, we connect that insight cautiously to Rocilinostat (ACY-1215), outlining how translational researchers can use selective HDAC6 inhibition to test cancer-relevant mechanisms without conflating distinct pathways or overextending preclinical findings.

• IBDV VP3 Disrupts IRF7 to Promote Viral Replication

  2026-09-24

  A 2025 study identifies IBDV VP3 as a viral factor that interferes with IRF7 abundance and type I interferon signaling, helping very virulent IBDV replicate in chicken cells. The findings connect viral protein interactions with proteasome-associated IRF7 loss and suggest experiments to distinguish transcriptional suppression from protein turnover.

• Firefly Luciferase mRNA: Practical Assay Workflows

  2026-09-23

  Build a reproducible bioluminescent readout for transfection optimization, gene expression, and delivery studies with a modified firefly reporter. This guide pairs practical assay steps with clear limits on what luminescence can—and cannot—tell you about cell viability, nanoparticle delivery, and immune memory.

• MG-132: Probing Proteasome–Ferroptosis Crosstalk

  2026-09-23

  MG-132 is more than a conventional proteasome inhibitor control: it can serve as a mechanistic probe for the relationship between proteostasis, oxidative stress, apoptosis, and ferroptosis competence. This article explains how to use MG-132 and Z-LLL-al to interrogate OTUD3–SLC7A11 biology in clear cell renal cell carcinoma, design causally informative assays, distinguish pathway effects from proteotoxic confounding, and translate observations into a disciplined strategy for drug-resistance research.

• UBR5–TERT Control of Vascular Organoid Stress

  2026-09-22

  Zhao et al. identify the E3 ligase UBR5 as a regulator of TERT stability in human vascular models exposed to oxidative stress. Their results connect UBR5-dependent protein turnover with endothelial progenitor cell function, vascular organoid development, and senescence, suggesting a mechanistic route for protecting vascular tissue under pathological redox conditions.

• Native-Membrane Proteoforms and Drug Selectivity

  2026-09-22

  The reference study establishes a native-membrane mass spectrometry strategy for connecting protein modifications with ligand binding and complex assembly. Its rhodopsin, G-protein, and PDE6 results show how proteoform state can influence off-target drug recognition in ways that conventional cell assays and bottom-up proteomics may not resolve.

• CGP 55845 Hydrochloride: GABAB Antagonist

  2026-09-21

  CGP 55845 hydrochloride is a selective GABAB receptor antagonist used to separate receptor-dependent signaling from transporter-mediated effects in cellular and electrophysiological models. Its reported affinity, baclofen antagonism, and neurotransmitter-release effects support controlled in vitro neurotransmission assays, but no in vivo or clinical studies of the compound are reported.

• GhATL68b Links Ubiquitination to Cotton Fiber Growth

  2026-09-21

  A 2024 Plant Communications study identifies the RING-type E3 ligase GhATL68b as a regulator of cotton fiber development through ubiquitination of 2,4-dienoyl-CoA reductase, an enzyme involved in polyunsaturated fatty-acid β-oxidation. Genetic, biochemical, and metabolic-rescue experiments connect this pathway to fiber quality, membrane lipid composition, and cell elongation, offering a mechanistic framework for studying proteostasis in plant development.

• MLN2238: Proteasome β5 Inhibitor Workflows

  2026-09-20

  MLN2238 enables β5-focused proteasome inhibition for mechanistic studies in multiple myeloma, lymphoma, and drug-resistant cell models. This workflow connects biochemical potency with apoptosis, proteotoxic stress, and ROS–JNK–CREB signaling while addressing solubility, dosing, and assay-interpretation challenges.

• HyperScribe T7 High Yield RNA Synthesis Kit for OSCC

  2026-09-19

  Translate the LINC02613–LCP1 mechanism in oral squamous cell carcinoma into reproducible RNA pull-down, probe-generation, and RNA interference workflows. The HyperScribe™ platform combines high-yield T7 transcription with flexible labeling and modified-nucleotide options for mechanism-focused assays.

8464 records 1/565 page Next 12345 下5页 Last page